107 related articles for article (PubMed ID: 8311856)
1. [Adrenocortical tumors. I. Prognostic evaluation of a series of 17 cases using the Weiss criteria].
Wagner M; Walter PR; Ghnassia JP; Gasser B
Ann Pathol; 1993; 13(5):306-11. PubMed ID: 8311856
[TBL] [Abstract][Full Text] [Related]
2. A small adrenocortical carcinoma with aggressive behavior. An evaluation of criteria for malignancy.
Gandour MJ; Grizzle WE
Arch Pathol Lab Med; 1986 Nov; 110(11):1076-9. PubMed ID: 3778125
[TBL] [Abstract][Full Text] [Related]
3. Adrenocortical carcinomas: a 12-year clinicopathologic study of 15 cases.
Menon V; Krishnamurthy SV
Indian J Pathol Microbiol; 2006 Jan; 49(1):7-11. PubMed ID: 16625963
[TBL] [Abstract][Full Text] [Related]
4. Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors.
Gicquel C; Bertagna X; Gaston V; Coste J; Louvel A; Baudin E; Bertherat J; Chapuis Y; Duclos JM; Schlumberger M; Plouin PF; Luton JP; Le Bouc Y
Cancer Res; 2001 Sep; 61(18):6762-7. PubMed ID: 11559548
[TBL] [Abstract][Full Text] [Related]
5. The Weiss system for evaluating adrenocortical neoplasms: 25 years later.
Lau SK; Weiss LM
Hum Pathol; 2009 Jun; 40(6):757-68. PubMed ID: 19442788
[TBL] [Abstract][Full Text] [Related]
6. Weiss criteria in large adrenocortical tumors: a validation study.
Jain M; Kapoor S; Mishra A; Gupta S; Agarwal A
Indian J Pathol Microbiol; 2010; 53(2):222-6. PubMed ID: 20551521
[TBL] [Abstract][Full Text] [Related]
7. Risk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy?
Sturgeon C; Shen WT; Clark OH; Duh QY; Kebebew E
J Am Coll Surg; 2006 Mar; 202(3):423-30. PubMed ID: 16500246
[TBL] [Abstract][Full Text] [Related]
8. Profile and outcome of pure androgen-secreting adrenal tumors in women: experience of 21 cases.
Moreno S; Montoya G; Armstrong J; Leteurtre E; Aubert S; Vantyghem MC; Dewailly D; Wemeau JL; Proye C
Surgery; 2004 Dec; 136(6):1192-8. PubMed ID: 15657575
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of two different histopathological scoring systems for adrenocortical carcinomas.
van't Sant HP; Bouvy ND; Kazemier G; Bonjer HJ; Hop WC; Feelders RA; de Herder WW; de Krijger RR
Histopathology; 2007 Aug; 51(2):239-45. PubMed ID: 17593212
[TBL] [Abstract][Full Text] [Related]
10. Comparison of morphologic features and outcome of resected recurrent and nonrecurrent squamous cell carcinoma of the penis: a study of 81 cases.
Chaux A; Reuter V; Lezcano C; Velazquez EF; Torres J; Cubilla AL
Am J Surg Pathol; 2009 Sep; 33(9):1299-306. PubMed ID: 19471153
[TBL] [Abstract][Full Text] [Related]
11. Image cytometric DNA analysis of adrenocortical neoplasms as a prognostic parameter: a clinico-pathologic study of 13 patients.
Lü X; Stallmach T; Gebbers JO
Anal Cell Pathol; 1996 Oct; 12(1):1-11. PubMed ID: 8933905
[TBL] [Abstract][Full Text] [Related]
12. [Adrenal cortical tumors. Prognostic evaluation of a series of 12 cases using anti-PCNA antibodies].
Ghnassia JP; Wagner M; Gasser B; Walter PR
Ann Pathol; 1993; 13(5):312-6. PubMed ID: 7906124
[TBL] [Abstract][Full Text] [Related]
13. Adrenocortical neoplasms in young children: age as a prognostic factor.
Ahmed AA
Ann Clin Lab Sci; 2009; 39(3):277-82. PubMed ID: 19667412
[TBL] [Abstract][Full Text] [Related]
14. Histologic criteria for adrenocortical proliferative lesions: value of mitotic figure variability.
Blanes A; Diaz-Cano SJ
Am J Clin Pathol; 2007 Mar; 127(3):398-408. PubMed ID: 17276949
[TBL] [Abstract][Full Text] [Related]
15. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast.
Kleer CG; Giordano TJ; Braun T; Oberman HA
Mod Pathol; 2001 Mar; 14(3):185-90. PubMed ID: 11266524
[TBL] [Abstract][Full Text] [Related]
16. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
[TBL] [Abstract][Full Text] [Related]
17. Classification of adrenal cortical tumors: what limits for the pathological approach?
Tissier F
Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):877-85. PubMed ID: 21115156
[TBL] [Abstract][Full Text] [Related]
18. The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished cases.
Duregon E; Fassina A; Volante M; Nesi G; Santi R; Gatti G; Cappellesso R; Dalino Ciaramella P; Ventura L; Gambacorta M; Dei Tos AP; Loli P; Mannelli M; Mantero F; Berruti A; Terzolo M; Papotti M
Am J Surg Pathol; 2013 Sep; 37(9):1433-40. PubMed ID: 23774167
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
[TBL] [Abstract][Full Text] [Related]
20. Intraductal papillary or mucinous tumors (IPMT) of the pancreas: report of a case series and review of the literature.
Zamora C; Sahel J; Cantu DG; Heyries L; Bernard JP; Bastid C; Payan MJ; Sielezneff I; Familiari L; Sastre B; Barthet M
Am J Gastroenterol; 2001 May; 96(5):1441-7. PubMed ID: 11374680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]